Isoflurane
In clinical developmentAlso known as Fluriso, Forane, IsoSol, Isospire+4 more
Fluriso, Forane, IsoSol, Isospire, Terrell, Isoflurano, 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, Isofluranum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Inhaled Sedation in Critically Ill Patients: a Multicentre Randomized Clinical Trial
Sevoflurane/Dexmedetomidine vs. Isoflurane and Their Effects on Pediatric Emergence Delirium
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
- Benshoff ND1
- Dikranian K1
- Hartman RE1
- Izumi Y1
- Jevtovic-Todorovic V1
- Olney JW1
- Wozniak DF1
- Zorumski CF1
- University of Virginia Health System1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Acts on the same molecular target as Isoflurane, with 4 overlapping disease areas.
Studied across 4 of the same disease areas as Isoflurane in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials